Thrombolytic Therapy

D. Goodenberger

doi:10.1056/NEJM198102053040619

Thrombolytic Therapy

D. Goodenberger

Internal Medicine

Research output: Contribution to journal › Letter

1 Scopus citations

Abstract

To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis¹ reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports²^,³ have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.

Original language	English (US)
Pages (from-to)	360-361
Number of pages	2
Journal	New England Journal of Medicine
Volume	304
Issue number	6
DOIs	https://doi.org/10.1056/NEJM198102053040619
State	Published - Feb 5 1981

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJM198102053040619

Fingerprint Dive into the research topics of 'Thrombolytic Therapy'. Together they form a unique fingerprint.

Cite this

Goodenberger, D. (1981). Thrombolytic Therapy. New England Journal of Medicine, 304(6), 360-361. https://doi.org/10.1056/NEJM198102053040619

@article{bb7239165990470db1a3079afef6d962,

title = "Thrombolytic Therapy",

abstract = "To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis1 reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports2,3 have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.",

author = "D. Goodenberger",

year = "1981",

month = feb,

day = "5",

doi = "10.1056/NEJM198102053040619",

language = "English (US)",

volume = "304",

pages = "360--361",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "6",

}

TY - JOUR

T1 - Thrombolytic Therapy

AU - Goodenberger, D.

PY - 1981/2/5

Y1 - 1981/2/5

N2 - To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis1 reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports2,3 have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.

AB - To the Editor: The only disappointing feature in the article on thrombolytic therapy (October 9 issue) by Sharma, Burleson, and Sasahara was that it made no mention of the frequency of bleeding complications. Recently I received a curbside consultation from a friend whose mother had just had a diagnosis of subclavian-vein thrombosis. I expressed the opinion that although Coon and Willis1 reported satisfactory long-term results in that disorder with prompt anticoagulation, at least two other reports2,3 have suggested that long-term complications will ensue in the affected extremity in 50 per cent or more of the patients despite such treatment, and.

UR - http://www.scopus.com/inward/record.url?scp=0019378217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019378217&partnerID=8YFLogxK

U2 - 10.1056/NEJM198102053040619

DO - 10.1056/NEJM198102053040619

M3 - Letter

C2 - 7442782

AN - SCOPUS:0019378217

VL - 304

SP - 360

EP - 361

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 6

ER -